Browsing articles in "Emergency Use Authorization"

The Antibody Deception

Mar 11, 2021 // by Team FPS // advertising, antibodies, AstraZeneca, bamlanivumab, casirivimab, coronaviruses, Eli Lilly, Emergency Use Authorization, etesevimab, EUA, false positives, FDA, General, GlaxoSmithKline, government, imdevimab, immune system, immunity, media, money trail, monoclonal, Novartis, novel, pharma, pharmaceutical, regeneron, regulation, spin, validation // Comments Off

Source By Rosemary Frei, MScMarch 2, 2021 The world has been fixated for months on novel-coronavirus PCR testing, contact tracing and vaccination. Meanwhile, another major part of the Covid biomedical complex has received far less attention: the use of antibodies for detecting, diagnosing and treating infection with the novel coronavirus. Hundreds of antibodies have been approved […]

The Antibody Deception

Mar 11, 2021 // by Team FPS // advertising, antibodies, AstraZeneca, bamlanivumab, coronaviruses, Eli Lilly, Emergency Use Authorization, etesevimab, EUA, false positives, FDA, General, GlaxoSmithKline, government, imdevimab, immune system, immunity, media, money trail, monoclonal, Novartis, novel, pharma, pharmaceutical, regeneron, regulation, spin, validation // Comments Off